DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 4Breckenridge Pharmaceutical
03 8Apotex Inc
04 4Aurobindo Pharma Limited
05 4Bristol Laboratories Ltd
06 16Bristol Myers Squibb
07 12Celgene Corporation
08 4Cipla Medpro South Africa
09 4DR REDDY'S LABORATORIES LTD
10 2Eurolab
11 4Hetero Drugs
12 4JAMP PHARMA
13 16Juno Pharmaceuticals Pty Ltd
14 4Key Oncologics
15 4Laboratorio Eczane Pharma
16 4Natco Pharma (Canada) Inc
17 1Sakar Healthcare
18 16Sandoz B2B
19 4Tecnimede
20 4Teva Pharmaceutical Industries
21 4Viatris
22 4XYZ Pharma
01 10CAP
02 24CAPSULE
03 32CAPSULE;ORAL
04 4Caps
05 12Capsule
06 4Capsule, hard
07 1Capsules
08 4HARD CAPSULES
09 4Oral Solid Dosage Form
10 1Pomalidomide 1Mg 21 Combined Oral Use
11 1Pomalidomide 2Mg 21 Combined Oral Use
12 1Pomalidomide 3Mg 21 Combined Oral Use
13 1Pomalidomide 4Mg 21 Combined Oral Use
14 12capsule
15 24Blank
01 20DISCN
02 6Generic
03 4Lead Market Dossiers- Filed
04 4Lead Market Dossiers- Tentative\nApproved in US
05 4Originator
06 24Prescription
07 8RX
08 65Blank
01 4APO-POMALIDOMIDE
02 16Imnovid
03 1Imnovid 1 mg
04 1Imnovid 2 mg
05 1Imnovid 3 mg
06 1Imnovid 4 mg
07 4JAMP POMALIDOMIDE
08 4NAT-POMALIDOMIDE
09 28POMALIDOMIDE
10 8POMALYST
11 4Pomalidomida Eczane
12 1Pomalidomide 1 mg Cipla
13 1Pomalidomide 2 mg Cipla
14 1Pomalidomide 3 mg Cipla
15 1Pomalidomide 4 mg Cipla
16 12Pomalidomide Sandoz
17 8Pomalyst
18 1Pomaxel 3 mg
19 1Pomaxel 4 mg
20 16Pomolide
21 4REDDY-POMALIDOMIDE
22 4SANDOZ POMALIDOMIDE
23 13Blank
01 4Argentina
02 36Australia
03 24Canada
04 9India
05 4Italy
06 4Norway
07 4Portugal
08 10South Africa
09 4Sweden
10 4Switzerland
11 32USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210111
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2024-06-11
Application Number : 210164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2024-06-11
Application Number : 210164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2024-06-11
Application Number : 210164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2024-06-11
Application Number : 210164
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2020-10-30
Application Number : 210249
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALYST
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2013-02-08
Application Number : 204026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALYST
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2013-02-08
Application Number : 204026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALYST
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2013-02-08
Application Number : 204026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALYST
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2013-02-08
Application Number : 204026
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2024-09-26
Application Number : 210236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2024-09-26
Application Number : 210236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2024-09-26
Application Number : 210236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2024-09-26
Application Number : 210236
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 1MG
Packaging :
Approval Date : 2022-05-04
Application Number : 209956
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 2MG
Packaging :
Approval Date : 2022-05-04
Application Number : 209956
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2022-05-04
Application Number : 209956
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : POMALIDOMIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 4MG
Packaging :
Approval Date : 2022-05-04
Application Number : 209956
Regulatory Info : DISCN
Registration Country : USA
